Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;9(1-2):56-61.
doi: 10.1159/000531006. Epub 2023 May 11.

Edge Creep: Increased Pigmentation at the Border of Choroidal Melanomas Treated with Plaque Brachytherapy

Affiliations

Edge Creep: Increased Pigmentation at the Border of Choroidal Melanomas Treated with Plaque Brachytherapy

Elaine M Binkley et al. Ocul Oncol Pathol. 2023 Aug.

Abstract

Introduction: There is an increase in pigmentation that occurs in many tumors following plaque brachytherapy for choroidal melanoma. Correctly distinguishing between increased pigment at the tumor border versus true growth is imperative. We performed a retrospective review of patients treated with I-125 brachytherapy for choroidal melanoma at our institution to study this phenomenon.

Methods: Records were reviewed for all patients undergoing plaque brachytherapy for uveal melanoma for a 5-year period (N = 195). Patients with iris and anterior tumors were excluded. Tumors treated more than 31 days after presentation were excluded. Fundus images for patients with increased pigmentation at any of the borders of the tumor at 6-month follow-up that extended beyond the initial pigmented margin were included (N = 20; 8 F, 12 M). Imaging at the last follow-up was reviewed, and it was confirmed that all tumors involuted appropriately with no evidence of local recurrence. The date of initial exam, time to treatment, and follow-up interval were recorded for each included patient.

Results: Twenty patients (10%) exhibited increased pigment deposition at any of the borders of the tumor at 6-month follow-up that extended beyond the initial pigmented margin. Average tumor thickness was 3.2 mm (1.3-5.1); average largest tumor basal diameter was 11.6 mm (7-15.5). Average time from diagnosis to treatment was 25 days (17-31). Average length of follow-up was 35 months (16-68). No patient developed recurrence during the duration of follow-up, and 1 patient had developed metastasis.

Conclusion: We describe the phenomenon of increased pigment deposition, "edge creep," at the borders of choroidal melanomas treated with plaque brachytherapy that gave the appearance of initial tumor growth but then subsequently remained stable over time. It is important that treating ocular oncologists be aware of this phenomenon to avoid unnecessary diagnosis of local recurrence.

Keywords: Brachytherapy; Choroidal melanoma; Tumor regression; Uveal melanoma.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Fig. 1.
Fig. 1.
Clarus fundus photograph for representative patient 1. Images at presentation (a), 7 months post-treatment (b), and 29 months post-treatment (c). Dashed circle shows the area around the tumor at presentation with an amelanotic surrounding rim and the same location on subsequent images for comparison. Arrows indicate areas of increased pigment that remained stable at the last follow-up.
Fig. 2.
Fig. 2.
Clarus fundus photograph for representative patient 2. Images at presentation (a), 6 months post-treatment (b), and 28 months post-treatment (c). Dashed circle shows the area around the tumor at presentation with an amelanotic surrounding rim and the same location on subsequent images for comparison. Arrows indicate areas of increased pigment that remained stable at the last follow-up.
Fig. 3.
Fig. 3.
Clarus fundus photograph for representative patient 3 with optical coherence tomography (OCT) over the tumor border. Clarus fundus photograph at presentation (a) and OCT over the superior tumor border (b) showing replacement of the choroid in the more lightly pigmented portion of the lesion. Clarus fundus photograph at 6-month follow-up (c) and OCT showing replacement of the choroid at the now more heavily pigmented border (d) (registration artifact shows that this is not in the exact same location as the OCT in b). Dashed circle shows increased pigment at all borders of the tumor.

References

    1. Shields CL, Sioufi K, Srinivasan A, Di Nicola M, Masoomian B, Barna LE, et al. . Visual outcome and millimeter incremental risk of metastasis in 1780 patients with small choroidal melanoma managed by plaque radiotherapy. JAMA Ophthalmol. 2018;136(12):1325–33. 10.1001/jamaophthalmol.2018.3881. - DOI - PMC - PubMed
    1. Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, et al. . Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology. 2001;108(2):348–66. 10.1016/s0161-6420(00)00526-1. - DOI - PubMed
    1. Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, et al. . Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. Ophthalmology. 2002;109(10):1838–49. 10.1016/s0161-6420(02)01181-8. - DOI - PubMed
    1. Maheshwari A, Finger PT. Regression patterns of choroidal melanoma: after palladium-103 ((103)Pd) plaque brachytherapy. Eur J Ophthalmol. 2018;28(6):722–30. 10.1177/1120672118776146. - DOI - PMC - PubMed
    1. Ophthalmic Oncology Task Force . Local recurrence significantly increases the risk of metastatic uveal melanoma. Ophthalmology. 2016;123(1):86–91. 10.1016/j.ophtha.2015.09.014. - DOI - PubMed